U.S. flag

An official website of the United States government

New/Reinstated & Terminated Labeler Information

The information below identifies new/reinstated & terminated labelers. This page will be updated as new information is available so please check back often.

For definitions of optional and mandatory effective dates, please see the Medicaid National Drug Rebate Agreement (NDRA). Additionally, the Drug Manufacturer Contact Information contains Optional Effective Date, Termination Date (if applicable), and Legal, Invoice and Technical Contact information for each drug company participating in the MDRP. 

New/Reinstated Labelers

Labeler CodeLabeler NameOptional Effective Date (for State Coverage)Mandatory Effective Date (for State Coverage)
81033KESIN PHARMA CORPORATION09/18/202301/01/2024
72526SHANDONG LUYE PHARMACEUTICAL CO., LTD.09/18/202301/01/2024
82829IVERIC BIO, INC.09/06/202301/01/2024
71349VERRICA PHARMACEUTICALS, INC.08/30/202301/01/2024
81942TARSUS PHARMACEUTICALS, INC.08/30/202301/01/2024
70095SUN PHARMACEUTICAL INDUSTRIES LIMITED08/22/202301/01/2024
82685OLIVA THERAPEUTICS, LLC08/15/202301/01/2024
83592TRUE MARKER PHARMACEUTICALS, INC.08/08/202301/01/2024
83257BIOCON BIOLOGICS INC08/01/202310/01/2023
72542ACER THERAPEUTICS07/31/202310/01/2023
63824RECKITT BENCKISER, INC.07/27/202310/01/2023
72336LIFSA DRUGS LLC07/18/202310/01/2023
58284BRAEBURN, INC.07/18/202310/01/2023
82194KRYSTAL BIOTECH, INC.07/07/202310/01/2023
73179REATA PHARMACEUTICALS, INC.07/05/202310/01/2023
82705GENMAB US, INC.06/02/202310/01/2023
51097ALEXZA PHARMACEUTICALS INC.05/30/202310/01/2023
73441GAMIDA CELL INC.05/25/202310/01/2023
69087TOLMAR, INC.05/23/202310/01/2023
82260BAUSCH & LOMB AMERICAS INC.05/23/202310/01/2023
81802ORPHALAN05/22/202310/01/2023
81927SHORLA PHARMA LTD05/22/202310/01/2023

Terminated Labelers

Labeler CodeLabeler NameEffective Date
24689APNAR PHARMA LP10/01/2023
64543CAPELLON PHARMACEUTICALS, LTD.10/01/2023
42847CURRAX PHARMACEUTICALS, LLC.10/01/2023
44183CURRAX PHARMACEUTICALS, LLC.10/01/2023
51267NALPROPION PHARMACEUTICALS10/01/2023
60258CURRAX PHARMACEUTICALS LLC10/01/2023
65224PERSION PHARMACEUTICALS, LLC.10/01/2023
71777LOXO ONCOLOGY, INC.10/01/2023
72000NABRIVA THERAPEUTICS US, INC.10/01/2023
00813PHARMICS INC.10/01/2023
71428GLASSHOUSE PHARMACEUTICALS LLC10/01/2023
71518BAUDAX BIO, INC.10/01/2023

For questions, please contact MDRP Operations at MDROperations@cms.hhs.gov.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on New/Reinstated & Terminated Labelers and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.

Page last updated on September 20, 2023